The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)

British Journal of Cancer

Volumn 111, Issue 4, 2014, Pages 807-816

  Hakami, F ^a,b   Darda, L ^a   Stafford, P ^a   Woll, P ^a   Lambert, D W ^a   Hunter, K D ^a,c  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

head and neck; HNSCC; HOX genes; HOXD10; metastasis; miR 146a

Indexed keywords

HOX PROTEIN; MICRORNA 146A; PROTEIN HOXD10; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANGIOMOTIN GENE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL ADHESION; CELL ADHESION ASSAY; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; GENE OVEREXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HOXD10 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH NODE METASTASIS; ONCOGENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TISSUE MICROARRAY; TUMOR INVASION;

CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HOMEODOMAIN PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICRORNAS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTOME;

EID: 84906082609     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.372     Document Type: Article

References (41)

1. Abe M, Hamada J, Takahashi O, Takahashi Y, Tada M, Miyamoto M, Morikawa T, Kondo S, Moriuchi T (2006) Disordered expression of HOX genes in human non-small cell lung cancer. Oncol Rep 15(4): 797-802.
2. Agrawal N, Frederick MJ, Pickering CR, Bettegowda C, Chang K, Li RJ, Fakhry C, Xie TX, Zhang J, Wang J, Zhang N, El-Naggar AK, Jasser SA, Weinstein JN, Trevino L, Drummond JA, Muzny DM, Wu Y, Wood LD, Hruban RH, Westra WH, Koch WM, Califano JA, Gibbs RA, Sidransky D, Vogelstein B, Velculescu VE, Papadopoulos N, Wheeler DA, Kinzler KW, Myers JN (2011) Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 333(6046): 1154-1157.
3. Baffa R, Fassan M, Volinia S, O'Hara B, Liu CG, Palazzo JP, Gardiman M, Rugge M, Gomella LG, Croce CM, Rosenberg A (2009) MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 219(2): 214-221.
4. Cartharius K, Frech K, Grote K, Klocke B, Haltmeier M, Klingenhoff A, Frisch M, Bayerlein M, Werner T (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21(13): 2933-2942.
5. Chen G, Umelo IA, Lv S, Teugels E, Fostier K, Kronenberger P, Dewaele A, Sadones J, Geers C, De Greve J (2013) miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLoS One 8(3): e60317.
6. Chen H, Chung S, Sukumar S (2004) HOXA5-induced apoptosis in breast cancer cells is mediated by caspases 2 and 8. Mol Cell Biol 24(2): 924-935.
7. Detre S, Saclani Jotti G, Dowsett M (1995) A "quickscore" method for immunohistochemical semiquantitation: validation for oestrogen receptor in breast carcinomas. J Clin Pathol 48(9): 876-878.
8. Eklund EA (2007) The role of HOX genes in malignant myeloid disease. Curr Opin Hematol 14(2): 85-89.
9. Ernkvist M, Birot O, Sinha I, Veitonmaki N, Nystrom S, Aase K, Holmgren L (2008) Differential roles of p80-and p130-angiomotin in the switch between migration and stabilization of endothelial cells. Biochim Biophys Acta 1783(3): 429-437.
10. Gilbert PM, Mouw JK, Unger MA, Lakins JN, Gbegnon MK, Clemmer VB, Benezra M, Licht JD, Boudreau NJ, Tsai KK, Welm AL, Feldman MD, Weber BL, Weaver VM (2010) HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. J Clin Invest 120(5): 1535-1550.
11. Halees AS, Leyfer D, Weng Z (2003) PromoSer: A large-scale mammalian promoter and transcription start site identification service. Nucleic Acids Res 31(13): 3554-3559.
12. Han X, Yan S, Weijie Z, Feng W, Liuxing W, Mengquan L, Qingxia F (2014) Critical role of miR-10b in transforming growth factor-beta1-induced epithelial-mesenchymal transition in breast cancer. Cancer Gene Ther 21(2): 60-67.
13. Hearnden V, Lomas H, Macneil S, Thornhill M, Murdoch C, Lewis A, Madsen J, Blanazs A, Armes S, Battaglia G (2009) Diffusion studies of nanometer polymersomes across tissue engineered human oral mucosa. Pharm Res 26(7): 1718-1728.
14. Hunter KD, Thurlow JK, Fleming J, Drake PJ, Vass JK, Kalna G, Higham DJ, Herzyk P, Macdonald DG, Parkinson EK, Harrison PR (2006) Divergent routes to oral cancer. Cancer Res 66(15): 7405-7413.
15. Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR (2009) Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res 69(4): 1279-1283.
16. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11(1): 9-22.
17. Liu Z, Zhu J, Cao H, Ren H, Fang X (2012) miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol 40(5): 1553-1560.
18. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW, Weinberg RA (2010) Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28(4): 341-347.
19. Ma L, Teruya-Feldstein J, Weinberg R (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449(7163): 682-688.
20. Messeguer X, Escudero R, Farre D, Nunez O, Martinez J, Alba MM (2002) PROMO: detection of known transcription regulatory elements using species-tailored searches. Bioinformatics 18(2): 333-334.
21. Morgan R, Boxall A, Harrington KJ, Simpson GR, Gillett C, Michael A, Pandha HS (2012) Targeting the HOX/PBX dimer in breast cancer. Breast Cancer Res Treat 136(2): 389-398.
22. Nakayama I, Shibazaki M, Yashima-Abo A, Miura F, Sugiyama T, Masuda T, Maesawa C (2013) Loss of HOXD10 expression induced by upregulation of miR-10b accelerates the migration and invasion activities of ovarian cancer cells. Int J Oncol 43(1): 63-71.
23. Paramasivam M, Sarkeshik A, Yates JR, Fernandes MJG, McCollum D (2011) Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol Biol Cell 22(19): 3725-3733.
24. Picchi J, Trombi L, Spugnesi L, Barachini S, Maroni G, Brodano GB, Boriani S, Valtieri M, Petrini M, Magli MC (2013) HOX and TALE signatures specify human stromal stem cell populations from different sources. J Cell Physiol 228(4): 879-889.
25. Pickering CR, Zhang J, Yoo SY, Bengtsson L, Moorthy S, Neskey DM, Zhao M, Ortega Alves MV, Chang K, Drummond J, Cortez E, Xie TX, Zhang D, Chung W, Issa JP, Zweidler-McKay PA, Wu X, El-Naggar AK, Weinstein JN, Wang J, Muzny DM, Gibbs RA, Wheeler DA, Myers JN, Frederick MJ (2013) Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers. Cancer Discov 3(7): 770-781.
26. Ranahan WP, Han Z, Smith-Kinnaman W, Nabinger SC, Heller B, Herbert BS, Chan R, Wells CD (2011) The adaptor protein AMOT promotes the proliferation of mammary epithelial cells via the prolonged activation of the extracellular signal-regulated kinases. Cancer Res 71(6): 2203-2211.
27. Rice KL, Licht JD (2007) HOX deregulation in acute myeloid leukemia. J Clin Invest 117(4): 865-868.
28. Rinn JL, Kertesz M, Wang JK, Squazzo SL, Xu X, Brugmann SA, Goodnough LH, Helms JA, Farnham PJ, Segal E, Chang HY (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by Noncoding RNAs. Cell 129(7): 1311-1323.
29. Rodini CO, Xavier FC, Paiva KB, De Souza Setubal Destro MF, Moyses RA, Michaluarte P, Carvalho MB, Fukuyama EE, Head Neck, Genome Project G, Tajara EH, Okamoto OK, Nunes FD (2012) Homeobox gene expression profile indicates HOXA5 as a candidate prognostic marker in oral squamous cell carcinoma. Int J Oncol 40(4): 1180-1188.
30. Severino P, Bruggemann H, Andreghetto FM, Camps C, Klingbeil Mde F, de Pereira WO, Soares RM, Moyses R, Wunsch-Filho V, Mathor MB, Nunes FD, Ragoussis J, Tajara EH (2013) MicroRNA expression profile in head and neck cancer: HOX-cluster embedded microRNA-196a and microRNA-10b dysregulation implicated in cell proliferation. BMC Cancer 13: 533.
31. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150(1): 76-85.
32. Vilen ST, Suojanen J, Salas F, Risteli J, Ylipalosaari M, Itkonen O, Koistinen H, Baumann M, Stenman UH, Sorsa T, Salo T, Nyberg P (2012) Trypsin-2 enhances carcinoma invasion by processing tight junctions and activating ProMT1-MMP. Cancer Invest 30(8): 583-592.
33. Wang LJ, Chen SJ, Xue M, Zhong J, Wang X, Gan LH, Lam EKY, Liu X, Zhang JB, Zhou TH, Yu J, Jin HC, Si JM (2012) Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis. Mol Med 18(3): 389-400.
34. Wardwell-Ozgo J, Dogruluk T, Gifford A, Zhang Y, Heffernan TP, van Doorn R, Creighton CJ, Chin L, Scott KL (2014) HOXA1 drives melanoma tumor growth and metastasis and elicits an invasion gene expression signature that prognosticates clinical outcome. Oncogene 33(8): 1017-1026.
35. Wu X, Chen H, Parker B, Rubin E, Zhu T, Lee JS, Argani P, Sukumar S (2006) HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res 66(19): 9527-9534.
36. Yao Q, Cao Z, Tu C, Zhao Y, Liu H, Zhang S (2013) MicroRNA-146a acts as a metastasis suppressor in gastric cancer by targeting WASF2. Cancer Lett 335(1): 219-224.
37. Yi CL, Shen ZW, Stemmer-Rachamimov A, Dawany N, Troutman S, Showe LC, Liu Q, Shimono A, Sudol M, Holmgren L, Stanger BZ, Kissil JL (2013) The p130 isoform of angiomotin is required for Yap-mediated hepatic epithelial cell proliferation and tumorigenesis. Science Signaling 6(291): ra77.
38. Yi CL, Troutman S, Fera D, Stemmer-Rachamimov A, Avila JL, Christian N, Persson NL, Shimono A, Speicher DW, Marmorstein R, Holmgren L, Kissil JL (2011) A tight junction-associated merlin-angiomotin complex mediates merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell 19(4): 527-540.
39. Zhang MQ (2003) Prediction, annotation, and analysis of human promoters. Cold Spring Harbor Symp Quant Biol 68: 217-225.
40. Zhao B, Li L, Lu Q, Wang LH, Liu CY, Lei QY, Guan KL (2011) Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Gene Dev 25(1): 51-63.
41. Ziegler EC, Ghosh S (2005) Regulating inducible transcription through controlled localization. Sci STKE 2005(284): re6.